SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-006265
Filing Date
2017-06-06
Accepted
2017-06-06 17:06:20
Documents
13
Period of Report
2017-06-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29203
2 ex99-1.htm EX-99.1 8672
3 ex99-1_001.jpg GRAPHIC 492150
4 ex99-1_002.jpg GRAPHIC 202357
5 ex99-1_003.jpg GRAPHIC 231456
6 ex99-1_004.jpg GRAPHIC 169593
7 ex99-1_005.jpg GRAPHIC 149122
8 ex99-1_006.jpg GRAPHIC 142487
9 ex99-1_007.jpg GRAPHIC 172503
10 ex99-1_008.jpg GRAPHIC 164265
11 ex99-1_009.jpg GRAPHIC 322034
12 ex99-2.htm EX-99.2 19147
13 ex99-2_001.jpg GRAPHIC 20961
  Complete submission text file 0001493152-17-006265.txt   2905731
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 17894821
SIC: 2834 Pharmaceutical Preparations